Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: Enhanced survival and mutagenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 660, Issue 1-2, 2009, Pages 40-46

  Bae, Dongsoon ^a   Camilli, Tura C ^a   Chun, Gina ^a   Lal, Madhu ^a   Wright, Kristen ^a   O'Brien, Travis J ^a   Patierno, Steven R ^a   Ceryak, Susan ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell survival; Genomic instability; Hexavalent chromium; Protein tyrosine phosphatase

Indexed keywords

CHROMIUM; DNA; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; VANADATE SODIUM;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA DAMAGE; GENE LOCUS; GENE MUTATION; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; LUNG FIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

CELL LINE; CELL SURVIVAL; CHROMIUM; ENZYME INHIBITORS; HUMANS; MUTAGENESIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN TYROSINE PHOSPHATASES;

EID: 58149457382     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.10.006     Document Type: Article

References (58)

1. Hahn W.C., and Weinberg R.A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2 (2002) 331-341
2. Vazquez F., and Sellers W.R. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochimica et Biophysica Acta 1470 (2000) M21-M35 [Review; 125 refs]
3. Chu Y., Solski P.A., Khosravi-Far R., Der C.J., and Kelly K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271 (1996) 6497-6501
4. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7 (2006) 833-846
5. Ostman A., Hellberg C., and Bohmer F.D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer. 6 (2006) 307-320
6. Chromium, nickel and welding, IARC Monogr Eval. Carcinog. Risks Hum., 49:1-648., (1990) 1-648.
7. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17 (1990) 189-215
8. O'Brien T.J., Ceryak S., and Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. 533 (2003) 3-36
9. Plunkett E.R. Handbook of Industrial Toxicology (1976), Chemical Publishing, New York, NY
10. Cassarett and Doull's Toxicology, Maxwell-MacMillan-Pergamon, New York, New York, 1991.
11. Ceryak S., Zingariello C., O'Brien T., and Patierno S.R. Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium(VI)-treated human lung fibroblasts: lack of effect of ERK. Mol. Cell. Biochem. 255 (2004) 139-149
12. Hamdan S., Morse B., and Reinhold D. Nickel subsulfide is similar to potassium dichromate in protecting normal human fibroblasts from the mutagenic effects of benzo[a]pyrene diolepoxide. Envir. Mol. Mutagenesis 33 (1999) 211-218
13. Pritchard D.E., Singh J., Carlisle D.L., Patierno S.R., and Cyclosporin. A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis 21 (2000) 2027-2033
14. Pritchard D.E., Ceryak S., Ha L., Fornsaglio J.L., Hartman S.K., O'Brien T.J., and Patierno S.R. Mechanism of apoptosis and determination of cellular fate in chromium(VI)-exposed populations of telomerase-immortalized human fibroblasts. Cell Growth Differ. 12 (2001) 487-496
15. Vilcheck S.K., O'Brien T.J., Pritchard D.E., Ha L., Ceryak S., Fornsaglio J.L., and Patierno S.R. Fanconi anemia complementation group A cells are hypersensitive to chromium(VI)-induced toxicity. Environ. Health Perspect. 110 Suppl 5 (2002) 773-777
16. Yang J.L., Hsieh Y.C., Wu C.W., and Lee T.C. Mutational specificity of chromium(VI) compounds in the hprt locus of Chinese hamster ovary-K1 cells. Carcinogenesis 13 (1992) 2053-2057
17. Cheng L., Liu S., and Dixon K. Analysis of repair and mutagenesis of chromium-induced DNA damage in yeast, mammalian cells, and transgenic mice. Environ. Health Perspect. 106 Suppl 4 (1998) 1027-1032
18. Blume-Jensen P., and Hunter T. Oncogenic kinase signalling. Nature 411 (2001) 355-365
19. Easty D., Gallagher W., and Bennett D.C. Protein tyrosine phosphatases, new targets for cancer therapy. Curr. Cancer Drug Targets 6 (2006) 519-532
20. Yi T., and Lindner D. The role and target potential of protein tyrosine phosphatases in cancer. Curr. Oncol. Rep. 10 (2008) 114-121
21. Zhang Z.Y. Protein tyrosine phosphatases: prospects for therapeutics. Curr. Opin. Chem Biol. 5 (2001) 416-423
22. Gordon J.A. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201 477-82 (1991) 477-482
23. Scheving L.A., Thomas J.R., and Zhang L. Regulation of intestinal tyrosine phosphorylation and programmed cell death by peroxovanadate. Am. J. Physiol. 277 (1999) C572-C579
24. Matsumoto J., Morioka M., Hasegawa Y., Kawano T., Yoshinaga Y., Maeda T., Yano S., Kai Y., Fukunaga K., and Kuratsu J. Sodium orthovanadate enhances proliferation of progenitor cells in the adult rat subventricular zone after focal cerebral ischemia. J. Pharmacol. Exp. Ther. 318 (2006) 982-991
25. Feng Y., Bhatt A.J., Fratkin J.D., and Rhodes P.G. Neuroprotective effects of sodium orthovanadate after hypoxic-ischemic brain injury in neonatal rats. Brain Res. Bull. 76 (2008) 102-108
26. Wu D.N., Pei D.S., Wang Q., and Zhang G.Y. Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus. Neurosci. Lett. 404 (2006) 98-102
27. Todorov L.D., Mihaylova-Todorova S.T., Choe S.M., and Westfall D.P. Facilitation of the purinergic contractile response of the guinea pig vas deferens by sodium orthovanadate. J. Pharmacol. Exp. Ther. 312 (2005) 407-416
28. Wang X.M., Huang T.H., Xie Q.D., Zhang Q.J., and Ruan Y. Effect of dynein inhibitor on mouse oocyte in vitro maturation and its cyclin B1 mRNA level. Biomed. Environ. Sci. 17 (2004) 341-349
29. Furlong F., Finlay D., and Martin F. PTPase inhibition restores ERK1/2 phosphorylation and protects mammary epithelial cells from apoptosis. Biochem. Biophys. Res. Commun. 336 (2005) 1292-1299
30. Chen X., Tian L.H., Xie H.F., Shi W., Feng H., Li J., and Chen F.W. Effects of CD147 on the production of matrix metalloproteinase-9 by fibroblasts and the invasion of melanoma cells. Zhong. Nan. Da. Xue. Xue. Bao. Yi. Xue. Ban. 30 (2005) 249-252
31. Yang P., Dankowski A., and Hagg T. Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats. Eur. J. Neurosci. 25 (2007) 1332-1340
32. Bhuiyan M.S., Takada Y., Shioda N., Moriguchi S., Kasahara J., and Fukunaga K. Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein. Cardiovasc. Ther. 26 (2008) 10-23
33. Smith J.B. Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 6162-6166
34. Jones T.R., and Reid T.W. Sodium orthovanadate stimulation of DNA synthesis in Nakano mouse lens epithelial cells in serum-free medium. J. Cell Physiol. 121 (1984) 199-205
35. Zhang Z., Leonard S.S., Huang C., Vallyathan V., Castranova V., and Shi X. Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radical Biol. Med. 34 (2003) 1333-1342
36. Huang C., Zhang Z., Ding M., Li J., Ye J., Leonard S.S., Shen H.M., Butterworth L., Lu Y., Costa M., Rojanasakul Y., Castranova V., Vallyathan V., and Shi X. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J. Biol. Chem. 275 (2000) 32516-32522
37. Hahn W.C., and Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 347 (2002) 1593-1603
38. Jiang H., Luo S., and Li H. Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint. J. Biol. Chem. 280 (2005) 20651-20659
39. Powell S.N., DeFrank J.S., Connell P., Eogan M., Preffer F., Dombkowski D., Tang W., and Friend S. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55 (1995) 1643-1648
40. Bache M., Pigorsch S., Dunst J., Wurl P., Meye A., Bartel F., Schmidt H., Rath F.W., and Taubert H. Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53. Int. J. Cancer. 20 96 (2001) 110-117
41. Foijer F., Simonis M., van Vliet M., Wessels L., Kerkhoven R., Sorger P.K., and Te R.H. Oncogenic pathways impinging on the G2-restriction point. Oncogene 27 (2008) 1142-1154
42. Knauf J.A., Ouyang B., Knudsen E.S., Fukasawa K., Babcock G., and Fagin J.A. Oncogenic RAS induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints. J. Biol. Chem. 281 (2006) 3800-3809
43. Saavedra H.I., Knauf J.A., Shirokawa J.M., Wang J., Ouyang B., Elisei R., Stambrook P.J., and Fagin J.A. The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway. Oncogene 19 (2000) 3948-3954
44. Kandel E.S., Skeen J., Majewski N., Di Cristofano A., Pandolfi P.P., Feliciano C.S., Gartel A., and Hay N. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol. Cell. Biol. 22 (2002) 7831-7841
45. Mailhes J.B., Hilliard C., Fuseler J.W., and London S.N. Vanadate, an inhibitor of tyrosine phosphatases, induced premature anaphase in oocytes and aneuploidy and polyploidy in mouse bone marrow cells. Mutat. Res. 538 (2003) 101-107
46. Ciranni R., Antonetti M., and Migliore L. Vanadium salts induce cytogenetic effects in vivo treated mice. Mutat. Res. 343 (1995) 53-60
47. Migliore L., Zotti-Martelli L., and Scarpato R. Detection of chromosome loss and gain induced by griseofulvin, estramustine, and vanadate in binucleated lymphocytes using FISH analysis. Environ. Mol. Mutagen. 34 (1999) 64-68
48. Migliore L., Scarpato R., and Falco P. The use of fluorescence in situ hybridization with a beta-satellite DNA probe for the detection of acrocentric chromosomes in vanadium-induced micronuclei. Cytogenet. Cell Genet. 69 (1995) 215-219
49. Ha L., Ceryak S., and Patierno S.R. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein: requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278 (2003) 17885-17894
50. Horton J.K., Stefanick D.F., Kedar P.S., and Wilson S.H. ATR signaling mediates an S-phase checkpoint after inhibition of poly(ADP-ribose) polymerase activity. DNA Repair (Amst). 6 (2007) 742-750
51. Flora S.D. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 21 (2000) 533-541 [Review; refs]
52. Ha L., Ceryak S., and Patierno S.R. Generation of S phase-dependent DNA double strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of {gamma}-H2AX. Carcinogenesis (2004)
53. O'Brien T.J., Brooks B.R., and Patierno S.R. Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells. Mol. Cell Biochem. 279 (2005) 85-95
54. Reynolds M., Peterson E., Quievryn G., and Zhitkovich A. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J. Biol. Chem. 279 (2004) 30419-30424
55. Xie H., Wise S.S., Holmes A.L., Xu B., Wakeman T.P., Pelsue S.C., Singh N.P., and Wise Sr. J.P. Carcinogenic lead chromate induces DNA double-strand breaks in human lung cells. Mutat. Res. 586 (2005) 160-172
56. Wakeman T.P., Kim W.J., Callens S., Chiu A., Brown K.D., and Xu B. The ATM-SMC1 pathway is essential for activation of the chromium[VI]-induced S-phase checkpoint. Mutat. Res. 554 (2004) 241-251
57. Hailer M.K., Slade P.G., Martin B.D., Rosenquist T.A., and Sugden K.D. Recognition of the oxidized lesions spiroiminodihydantoin and guanidinohydantoin in DNA by the mammalian base excision repair glycosylases NEIL1 and NEIL2. DNA Repair (Amst). 4 (2005) 41-50
58. Sobol R.W., and Wilson S.H. Mammalian DNA beta-polymerase in base excision repair of alkylation damage. Prog. Nucleic Acid Res. Mol. Biol. 68 (2001) 57-74